Trial on Lenalidomide Given as Maintenance Therapy for Relapsed Diffuse Large B Cell Lymphoma
Status:
Unknown status
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This phase II multi-institutional trial will explore the safety and efficacy of lenalidomide
monotherapy given as maintenance therapy following salvage chemo-immunotherapy in patients
with relapsed or refractory chemosensitive diffuse large B-cell lymphoma